COBAS® CMV - COFEPRIS Registration 139R2022 SSA
Access comprehensive regulatory information for COBAS® CMV (COBAS® CMV) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 139R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on February 22, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LA PRUEBA COBAS® CMV ES UNA PRUEBA DEAMPLIFICACIÓNDEÁCIDOSNUCLEICOSINVITROPARALAMEDICIÓNCUANTITATIVADELADNDELCITOMEGALOVIRUS(CMV) EN PLASMA HUMANO CONSERVADO EN EDTA.AGENTESDEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVO EN LABORATORIOS CLÍNICOS Ó DE GABINETE.
THE COBAS® CMV TEST IS A TEST FOR AMPLIFICATION OF NUCLEIC ACIDSINVITROPARALAM QUANTITATIVE ANALYSIS OF CYTOMEGALOVIRUS (CMV) IN HUMAN PLASMA CONSERVED IN EDTA. DIAGNOSTICAGENTSFORUSEINVITRO. FOR EXCLUSIVE USE IN CLINICAL OR CABINET LABORATORIES.